City Holding Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1M Sell
23,405
-122
-0.5% -$125K 3.17% 4
2026
Q1
$21.6M Sell
23,527
-432
-2% -$438K 2.71% 5
2025
Q4
$25.7M Buy
23,959
+431
+2% +$412K 3.17% 4
2025
Q3
$18M Buy
23,528
+195
+0.8% +$145K 2.26% 9
2025
Q2
$18.2M Buy
23,333
+53
+0.2% +$41.2K 2.38% 8
2025
Q1
$19.2M Sell
23,280
-410
-2% -$341K 2.71% 4
2024
Q4
$18.3M Sell
23,690
-1,341
-5% -$1.11M 2.59% 5
2024
Q3
$22.2M Sell
25,031
-1,547
-6% -$1.39M 3.08% 4
2024
Q2
$24.1M Sell
26,578
-882
-3% -$706K 3.56% 4
2024
Q1
$21.4M Sell
27,460
-1,613
-6% -$1.15M 3.2% 4
2023
Q4
$16.9M Sell
29,073
-877
-3% -$512K 2.73% 5
2023
Q3
$16.1M Sell
29,950
-2,506
-8% -$1.29M 2.87% 5
2023
Q2
$15.2M Sell
32,456
-864
-3% -$362K 2.62% 5
2023
Q1
$11.4M Sell
33,320
-1,167
-3% -$394K 2.06% 5
2022
Q4
$12.6M Sell
34,487
-1,017
-3% -$361K 2.36% 5
2022
Q3
$11.5M Sell
35,504
-2,314
-6% -$733K 2.28% 5
2022
Q2
$12.3M Sell
37,818
-1,929
-5% -$579K 2.31% 5
2022
Q1
$11.4M Sell
39,747
-25
-0.1% -$6.43K 1.84% 8
2021
Q4
$9.94M Buy
39,772
+237
+0.6% +$60.1K 1.66% 9
2021
Q3
$9.13M Sell
39,535
-20
-0.1% -$4.94K 1.56% 10
2021
Q2
$9.08M Buy
39,555
+682
+2% +$137K 1.6% 11
2021
Q1
$7.26M Buy
38,873
+373
+1% +$73K 1.38% 14
2020
Q4
$6.5M Buy
38,500
+1,945
+5% +$290K 1.36% 14
2020
Q3
$5.41M Buy
36,555
+215
+0.6% +$33.3K 1.23% 17
2020
Q2
$5.97M Buy
36,340
+827
+2% +$127K 1.48% 11
2020
Q1
$4.93M Sell
35,513
-342
-1% -$47K 1.49% 13
2019
Q4
$4.71M Buy
35,855
+369
+1% +$42.8K 1.12% 18
2019
Q3
$3.97M Buy
35,486
+170
+0.5% +$18.9K 1.03% 26
2019
Q2
$3.91M Sell
35,316
-9
-0% -$1.06K 1.06% 25
2019
Q1
$4.58M Buy
35,325
+535
+2% +$65.1K 1.29% 16
2018
Q4
$4.03M Sell
34,790
-10
-0% -$1.12K 1.31% 15
2018
Q3
$3.73M Sell
34,800
-275
-0.8% -$27.5K 1.07% 21
2018
Q2
$2.99M Sell
35,075
-260
-0.7% -$21.4K 0.92% 34
2018
Q1
$2.73M Buy
35,335
+2,100
+6% +$169K 0.87% 36
2017
Q4
$2.81M Sell
33,235
-227
-0.7% -$19.3K 0.89% 40
2017
Q3
$2.86M Buy
33,462
+2,115
+7% +$173K 0.96% 28
2017
Q2
$2.58M Buy
31,347
+190
+0.6% +$15.5K 0.91% 33
2017
Q1
$2.62M Buy
31,157
+505
+2% +$40.4K 0.98% 24
2016
Q4
$2.25M Buy
30,652
+865
+3% +$64.4K 0.88% 31
2016
Q3
$2.39M Buy
29,787
+1,805
+6% +$144K 1.03% 22
2016
Q2
$2.2M Buy
27,982
+6,100
+28% +$459K 0.98% 26
2016
Q1
$1.57M Sell
21,882
-300
-1% -$22.7K 0.79% 39
2015
Q4
$1.87M Buy
22,182
+75
+0.3% +$6.22K 0.96% 25
2015
Q3
$1.85M Sell
22,107
-1,426
-6% -$120K 1.01% 24
2015
Q2
$1.97M Buy
23,533
+650
+3% +$49.5K 1% 25
2015
Q1
$1.66M Sell
22,883
-450
-2% -$32K 0.85% 34
2014
Q4
$1.61M Sell
23,333
-352
-1% -$23.8K 0.84% 35
2014
Q3
$1.54M Buy
23,685
+725
+3% +$45.9K 0.85% 34
2014
Q2
$1.4M Sell
22,960
-250
-1% -$14.9K 0.81% 38
2014
Q1
$1.37M Buy
23,210
+150
+0.7% +$8.37K 0.83% 39
2013
Q4
$1.18M Buy
+23,060
New +$1.15M 0.74% 48

Other funds holding LLY

City Holding Co's LLY Position: Q2 2026 in Review

City Holding Co reduced its Eli Lilly (LLY) stake by 0.52% in Q2 2026, selling an estimated $125K and leaving 23,405 shares worth $28.1M. The position accounts for 3.17% of the portfolio, ranked #4.

City Holding Co first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • City Holding Co held 23,405 shares of Eli Lilly worth $28.1M as of Q2 2026.
  • City Holding Co sold 122 Eli Lilly shares in Q2 2026, an estimated $125K.
  • Eli Lilly made up 3.17% of City Holding Co's portfolio in Q2 2026, its #4 holding.
  • City Holding Co first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.